Member Exclusive

Genetically modified human umbilical cells could be a treatment for spinal cord injuries

Genetically modified human umbilical cord blood mononuclear cells have been shown to increase the number of Schwann cells in a murine model with spinal cord injuries. The results could lead to regenerative medicines for spinal cord injuries.

Go to the profile of Adam Tarring
Jul 09, 2018
0
0

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.

Register

No comments yet.